Skip to content

Role of CD4 cell counts in predicting disease outcome in covid positive patients

CD4 cell counts as a prognostic bio marker in Covid 19 infection in hospitalised patients - CD4 counts in Covid 19

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/02/031096
Enrollment
116
Registered
2021-02-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Government Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient diagnosed as covid 19 infected either by RTPCR or Rapid antigen test. Patients diagnosed as Covid 19 positive will be divided into Group A and Group B as per Revised Guidelines on Clinical Management of COVID â?? 19. Ministry of Health & Family Welfare Directorate General of Health Services (EMR Division) Government of India. (12) Group A â?? RT PCR or RAT positive Severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock will be considered as severe Covid infection Group B - RT PCR or RAT positive Uncomplicated illness and mild pneumonia will be considered as non-severe (mild/moderate) Covid infection

Exclusion criteria

Exclusion criteria: HIV infected patients Patients on immunosuppressive therapy or any disease or therapy known to affect the CD4 counts e.g. autoimmune disease, tuberculosis, patients on chronic steroids, etc

Design outcomes

Primary

MeasureTime frame
To determine the proportion of severe and mild covid patients with low CD4 countsTimepoint: Baseline

Secondary

MeasureTime frame
2. To assess the role of baseline CD4 counts in predicting disease outcome in a covid patient 3. To compare the recovery of CD4 counts between patients who remain RT PCR positive and those who turn RT PCR negative Timepoint: 6 months

Countries

India

Contacts

Public ContactGita Nataraj

Seth G S Medical College and KEM Hospital

gitanataraj@gmail.com9820067349

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026